This research project is investigatinng a new treatment for Rhegmatogenous Retinal Detachment. The new treatment is called Retinal Thermofusion (RTF) and uses a special laser device called iSeelrTM during surgery to treat RRD.

The retina is a sensitive layer at the back of the eye that converts light into images for our brain to process. When a tear forms in the retina, fluid can leak behind the retina, and can result in a detachment. If left untreated, retinal detachment can lead to severe vision loss.

Currently, retinal tears and detachments are fixed through a surgery known as vitrectomy, where the retina is repositioned, and secured in place with a laser. This usually requires putting a gas bubble or oil inside the eye that slowly disappears over several weeks.

A new method called Retinal Thermofusion (RTF), that uses the new iSeelr device, is being investigated and is designed to repair retinal tears without needing a gas bubble or oil. It is anticipated that this new method may result in a quicker recovery and lessen the risk of complications associated with the current standard of care surgical treatment.

Participation in this trial will last up to approximately 3 months, with up to 7 visits at our site.